Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
OM-174 is a synthetic lipid A analogue. It was developed by OM Pharma. It acts on Toll-like receptors 2 and 4. Its main focus is cancer treatment. It targets solid tumors. OM-174 boosts the immune system. It does not directly kill tumors. It triggers cytokine secretion. It also activates immune cells. These cells infiltrate tumors. This can cause tumor regression in experiments.
OM-174 is explored with chemotherapy. It aims to enhance efficacy. It stimulates the immune system. This happens after initial chemotherapy. The goal is to improve cancer treatment. It…